Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation: skin hyperpigmentation index (SHI) analysis
Aesthetic Medicine · 30.09.2025
DOI: 10.57662/am.v11i3.16222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Medicine, erschienen am 30.09.2025. Verfasst von Vera Vera und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
The study aimed to assess the safety and efficacy of microneedling (MN) combined with Polydeoxyribonucleotide (PDRN) Salmon 3% for treating facial hyperpigmentation.
Methods
Two patients, aged 40 and 50, underwent two MN sessions combined with PDRN 3%, spaced 3 weeks apart. Photos were taken before and after each visit, as well as at the final visit (6 weeks after baseline).
Results
Photos were analyzed through a Skin Hyperpigmentation Index (SHI) analysis. Both patients showed improved skin quality, brighter facial skin, and reduced facial hyperpigmentation based on SHI scores. No side effects were noted during or after treatment.
Conclusion
Combined therapy of MN and PDRN 3% shows promising outcomes in improving skin quality and hyperpigmentation. To the best of the author’s knowledge, these are the first reported cases of MN combined with PDRN 3% for reducing hyperpigmentation.
Schlagwörter
Zitieren
APA
Vera, V., & Praharsini, I. G. A. A. (2025). Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation: skin hyperpigmentation index (SHI) analysis. Aesthetic Medicine. https://doi.org/10.57662/am.v11i3.16222
Vancouver
Vera V, Praharsini IGAA. Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation: skin hyperpigmentation index (SHI) analysis. Aesthetic Medicine. 2025. doi:10.57662/am.v11i3.16222
BibTeX
@article{Vera2025,
author = {Vera, Vera and Praharsini, I Gusti Ayu Agung},
title = {Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation: skin hyperpigmentation index (SHI) analysis},
journal = {Aesthetic Medicine},
year = {2025},
doi = {10.57662/am.v11i3.16222}
}
EUVIMED